DECEMBER 2023LIFE SCIENCES REVIEW5CXO INSIGHTSCXO INSIGHTSFEATURED COMPANYseeDNAKinori Tomikane, CEO2026Unlocking The Potential of Next-Generation SequencingPeter René Hesse, Vice President Head of Genomics Business, QIAGEN22Ensuring Safe Drug Development with Regulatory ComplianceEnrique Blanco, Gral Director / Director Of Corp Operations Grupo Loeffler-Russek24Navigating the Future of Drug Safety: Insights from an International Symposium in Latin AmericaAna Laura Cruz Cortés, LATAM Pharmacovigilance & Technovigilance Manager, Laboratorios Sanfer28Gene Therapy--Therapeutic Viral Vectors; Manufacturing, Challenges, and InnovationRachel Legmann, PhD, Senior director of technology, gene therapy, Repligen CorpLAST WORD30From Complex to Compliance:3 Keys for Unlocking the Regulatory PathwayNicholas Smalley, Vice President Regulatory Affairs, Kindeva Drug DeliveryGENOMICSTOP 10SOLUTIONS PROVIDERS IN APAC - 2023MEDIZEN HUMANCAREMEDIZEN HUMANCARE
< Page 4 | Page 6 >